| Application no. and date | 14710620.7 (espacenet) (Federated) (European Patent Register), 20140305 | | Patent/reg. no. and date | DK/EP 2964638, 20170809 | | Publication date | 20160113 | | Priority no. and date | WO PCT/CN2013/072250, 20130306 | | EP pub. no. and date |
EP 2964638 20160113 | | Effective date | | | Applicant/owner | Astrazeneca AB, 151 85 Södertälje, SE | | Applicant ref. no. | P22966DKEP | | Inventor | LI, David, Yunzhi, AstraZeneca R&D China
Innovation Center China
Zhangjiang Hi-Tech Park
Shanghai 201203, CN,
WANG, Jiabing, AstraZeneca R&D China
Innovation Center China
Zhangjiang Hi-Tech Park
Shanghai 201203, CN,
YANG, Zhenfan, AstraZeneca R&D China
Innovation Center China
Zhangjiang Hi-Tech Park
Shanghai 201203, CN,
ZENG, Qingbei, AstraZeneca R&D China
Innovation Center China
Zhangjiang Hi-Tech Park
Shanghai 201203, CN,
ZHANG, Xiaolin, AstraZeneca R&D China
Innovation Center China
Zhangjiang Hi-Tech Park
Shanghai 201203, CN | | Representative | Patrade A/S, Ceresbyen 75, 8000 Århus C | | Opponent | | | IPC Class | A61K 31/495 (2006.01) , A61K 31/505 (2006.01) , C07D 403/12 (2006.01) | | Title | QUINAZOLIN-INHIBITORER TIL AKTIVERING AF MUTANTE FORMER AF EPIDERMAL VÆKSTFAKTOR RECEPTOR | | Int. application no. | GB2014050655 | | Int. publication no. | WO2014135876 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
